Does the media favor BSX or ALGN?

In the previous week, Boston Scientific had 6 more articles in the media than Align Technology. MarketBeat recorded 11 mentions for Boston Scientific and 5 mentions for Align Technology. Align Technology's average media sentiment score of 1.31 beat Boston Scientific's score of 0.39 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Align Technology 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BSX or MMSI?

In the previous week, Boston Scientific had 4 more articles in the media than Merit Medical Systems. MarketBeat recorded 11 mentions for Boston Scientific and 7 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.25 beat Boston Scientific's score of 0.39 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Merit Medical Systems 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BSX or AMN?

In the previous week, Boston Scientific had 7 more articles in the media than AMN Healthcare Services. MarketBeat recorded 11 mentions for Boston Scientific and 4 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.64 beat Boston Scientific's score of 0.39 indicating that AMN Healthcare Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral AMN Healthcare Services 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CAH or BSX?

In the previous week, Boston Scientific had 1 more articles in the media than Cardinal Health. MarketBeat recorded 11 mentions for Boston Scientific and 10 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 0.64 beat Boston Scientific's score of 0.39 indicating that Cardinal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardinal Health 3 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Boston Scientific (BSX) Competitors

$43.74 -0.37 (-0.83%)

Closing price 03:59 PM Eastern

Extended Trading

$43.81 +0.07 (+0.15%)

As of 06:26 PM Eastern

Compare

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

Should you buy Boston Scientific stock or one of its competitors? Boston Scientific's main competitors and comparable companies include Align Technology (ALGN), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), and Cardinal Health (CAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Boston Scientific compare to Align Technology?

Boston Scientific (NYSE:BSX) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

In the previous week, Boston Scientific had 6 more articles in the media than Align Technology. MarketBeat recorded 11 mentions for Boston Scientific and 5 mentions for Align Technology. Align Technology's average media sentiment score of 1.31 beat Boston Scientific's score of 0.39 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Align Technology	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific currently has a consensus price target of $70.19, suggesting a potential upside of 60.46%. Align Technology has a consensus price target of $206.36, suggesting a potential upside of 43.29%. Given Boston Scientific's stronger consensus rating and higher probable upside, equities research analysts plainly believe Boston Scientific is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	6 Hold rating(s)	23 Buy rating(s)	0 Strong Buy rating(s)	2.68
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67

Boston Scientific has higher revenue and earnings than Align Technology. Boston Scientific is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.16	$2.90B	$2.47	17.71
Align Technology	$4.03B	2.56	$410.35M	$5.75	25.05

Boston Scientific has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market.

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.3% of Boston Scientific shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Boston Scientific has a net margin of 17.50% compared to Align Technology's net margin of 9.99%. Boston Scientific's return on equity of 19.28% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.50%	19.28%	10.89%
Align Technology	9.99%	15.86%	10.32%

Summary

Boston Scientific beats Align Technology on 11 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Boston Scientific (NYSE:BSX) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 0.3% of Boston Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

HealthEquity has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market.

Boston Scientific has a net margin of 17.50% compared to HealthEquity's net margin of 17.36%. Boston Scientific's return on equity of 19.28% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Boston Scientific	17.50%	19.28%	10.89%

Boston Scientific has higher revenue and earnings than HealthEquity. Boston Scientific is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.49	$215.20M	$2.77	31.50
Boston Scientific	$20.07B	3.16	$2.90B	$2.47	17.71

In the previous week, Boston Scientific had 10 more articles in the media than HealthEquity. MarketBeat recorded 11 mentions for Boston Scientific and 1 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.83 beat Boston Scientific's score of 0.39 indicating that HealthEquity is being referred to more favorably in the media.

Company	Overall Sentiment
HealthEquity	Positive
Boston Scientific	Neutral

HealthEquity presently has a consensus price target of $112.20, suggesting a potential upside of 28.60%. Boston Scientific has a consensus price target of $70.19, suggesting a potential upside of 60.46%. Given Boston Scientific's higher possible upside, analysts plainly believe Boston Scientific is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92
Boston Scientific	2 Sell rating(s)	6 Hold rating(s)	23 Buy rating(s)	0 Strong Buy rating(s)	2.68

Summary

Boston Scientific beats HealthEquity on 9 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to Merit Medical Systems?

Boston Scientific (NYSE:BSX) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Boston Scientific has a net margin of 17.50% compared to Merit Medical Systems' net margin of 9.22%. Boston Scientific's return on equity of 19.28% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.50%	19.28%	10.89%
Merit Medical Systems	9.22%	13.75%	8.10%

Boston Scientific has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market.

In the previous week, Boston Scientific had 4 more articles in the media than Merit Medical Systems. MarketBeat recorded 11 mentions for Boston Scientific and 7 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.25 beat Boston Scientific's score of 0.39 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Merit Medical Systems	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has higher revenue and earnings than Merit Medical Systems. Boston Scientific is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.16	$2.90B	$2.47	17.71
Merit Medical Systems	$1.58B	3.32	$128.49M	$2.42	36.31

Boston Scientific currently has a consensus price target of $70.19, indicating a potential upside of 60.46%. Merit Medical Systems has a consensus price target of $100.00, indicating a potential upside of 13.80%. Given Boston Scientific's higher probable upside, equities analysts plainly believe Boston Scientific is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	6 Hold rating(s)	23 Buy rating(s)	0 Strong Buy rating(s)	2.68
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Boston Scientific beats Merit Medical Systems on 10 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to AMN Healthcare Services?

Boston Scientific (NYSE:BSX) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk.

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.3% of Boston Scientific shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Boston Scientific has a net margin of 17.50% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Boston Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.50%	19.28%	10.89%
AMN Healthcare Services	3.06%	19.92%	5.93%

In the previous week, Boston Scientific had 7 more articles in the media than AMN Healthcare Services. MarketBeat recorded 11 mentions for Boston Scientific and 4 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.64 beat Boston Scientific's score of 0.39 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
AMN Healthcare Services	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market.

Boston Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.16	$2.90B	$2.47	17.71
AMN Healthcare Services	$2.73B	0.50	-$95.70M	$2.68	13.04

Boston Scientific currently has a consensus price target of $70.19, indicating a potential upside of 60.46%. AMN Healthcare Services has a consensus price target of $36.00, indicating a potential upside of 2.98%. Given Boston Scientific's stronger consensus rating and higher possible upside, equities research analysts plainly believe Boston Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	6 Hold rating(s)	23 Buy rating(s)	0 Strong Buy rating(s)	2.68
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Boston Scientific beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

In the previous week, Boston Scientific had 1 more articles in the media than Cardinal Health. MarketBeat recorded 11 mentions for Boston Scientific and 10 mentions for Cardinal Health. Cardinal Health's average media sentiment score of 0.64 beat Boston Scientific's score of 0.39 indicating that Cardinal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardinal Health	3 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Boston Scientific has a net margin of 17.50% compared to Cardinal Health's net margin of 0.67%. Boston Scientific's return on equity of 19.28% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardinal Health	0.67%	-98.53%	4.69%
Boston Scientific	17.50%	19.28%	10.89%

Cardinal Health has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market.

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.1% of Cardinal Health shares are held by insiders. Comparatively, 0.3% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Boston Scientific has lower revenue, but higher earnings than Cardinal Health. Boston Scientific is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardinal Health	$254.25B	0.20	$1.71B	$7.23	30.96
Boston Scientific	$20.07B	3.16	$2.90B	$2.47	17.71

Cardinal Health presently has a consensus target price of $266.56, suggesting a potential upside of 19.10%. Boston Scientific has a consensus target price of $70.19, suggesting a potential upside of 60.46%. Given Boston Scientific's higher possible upside, analysts clearly believe Boston Scientific is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.84
Boston Scientific	2 Sell rating(s)	6 Hold rating(s)	23 Buy rating(s)	0 Strong Buy rating(s)	2.68

Summary

Boston Scientific beats Cardinal Health on 11 of the 16 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BSX vs. The Competition

Export

Metric	Boston Scientific	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$63.40B	$5.42B	$7.26B	$22.74B
Dividend Yield	N/A	1.79%	2.52%	3.68%
P/E Ratio	17.71	25.47	274.72	27.68
Price / Sales	3.16	43.55	606.70	20.20
Price / Cash	10.88	33.37	28.02	19.27
Price / Book	2.65	5.89	10.49	4.64
Net Income	$2.90B	$150.11M	$3.50B	$1.07B
7 Day Performance	-2.78%	-2.50%	-3.03%	-2.80%
1 Month Performance	-6.57%	-5.27%	-4.16%	-5.85%
1 Year Performance	-54.85%	5.79%	13.20%	5.75%

Boston Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BSX Boston Scientific	4.7821 of 5 stars	$43.75 -0.8%	$70.19 +60.5%	-55.1%	$63.40B	$20.07B	17.71	59,000
ALGN Align Technology	3.837 of 5 stars	$146.88 -0.5%	$206.36 +40.5%	+14.9%	$10.52B	$4.14B	25.54	20,290	Positive News
HQY HealthEquity	4.3186 of 5 stars	$94.52 -0.7%	$112.20 +18.7%	-8.4%	$7.82B	$1.36B	34.12	2,814
MMSI Merit Medical Systems	3.4583 of 5 stars	$85.49 +0.1%	$100.00 +17.0%	+8.5%	$5.10B	$1.52B	35.33	7,500	Analyst Forecast
AMN AMN Healthcare Services	1.415 of 5 stars	$34.15 -0.3%	$36.00 +5.4%	+81.5%	$1.32B	$3.43B	12.74	2,664

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BSX) was last updated on 9/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

How does Boston Scientific compare to Align Technology?

Summary

How does Boston Scientific compare to HealthEquity?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Summary

How does Boston Scientific compare to Cardinal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

How does Boston Scientific compare to Align Technology?

Does the media favor BSX or ALGN?

Do analysts rate BSX or ALGN?

Which has better valuation & earnings, BSX or ALGN?

Which has more risk and volatility, BSX or ALGN?

Do insiders and institutionals have more ownership in BSX or ALGN?

Is BSX or ALGN more profitable?

Summary

How does Boston Scientific compare to HealthEquity?

Do insiders & institutionals have more ownership in HQY or BSX?

Which has more volatility and risk, HQY or BSX?

Is HQY or BSX more profitable?

Which has higher valuation & earnings, HQY or BSX?

Does the media refer more to HQY or BSX?

Do analysts rate HQY or BSX?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Is BSX or MMSI more profitable?

Which has more volatility and risk, BSX or MMSI?

Does the media favor BSX or MMSI?

Which has higher valuation and earnings, BSX or MMSI?

Do analysts recommend BSX or MMSI?

Do insiders & institutionals have more ownership in BSX or MMSI?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Do institutionals and insiders have more ownership in BSX or AMN?

Is BSX or AMN more profitable?

Does the media favor BSX or AMN?

Which has more volatility & risk, BSX or AMN?

Which has better earnings & valuation, BSX or AMN?

Do analysts rate BSX or AMN?

Summary

How does Boston Scientific compare to Cardinal Health?

Does the media refer more to CAH or BSX?

Is CAH or BSX more profitable?

Which has more risk and volatility, CAH or BSX?

Do insiders and institutionals hold more shares of CAH or BSX?

Which has better earnings and valuation, CAH or BSX?

Do analysts rate CAH or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools